The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Saudi Arabia’s non-oil GDP grows 0.6%
- Brazil-Arab Galllery #67
- BIG Studios partners with Arab producer
- Dubai’s Amazing Creation enters Brazilian market
- Brazil-Arab Gallery #66
- Fertilizer costs weigh on Brazil’s ag logistics
- IMF forecasts Saudi economy to grow 1.7%
- Guggenheim Abu Dhabi to open in December
